Two Sigma Securities’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Two Sigma Securities's TVTX Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 11,192 shares worth $659K. The stake represents 0.05% of the portfolio and ranks #467 among its holdings.
343 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Two Sigma Securities held 11,192 shares of Travere Therapeutics worth $659K as of Q3 2026.
- Travere Therapeutics was a new Two Sigma Securities position in Q3 2026.
- Travere Therapeutics made up 0.05% of Two Sigma Securities's portfolio in Q3 2026, its #467 holding.
- 343 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.